Status | Study |
Recruiting |
Study Name: Italian Network MDS Registry Condition: Myelodysplastic-Myeloproliferative Diseases Date: 2016-05-18 |
Recruiting |
Study Name: Myeloproliferative Neoplasms (MPNs) Patient Registry Condition: Primary Myelofibrosis Polycythemia Vera Essential Thromboc Date: 2016-03-24 Interventions: Other: Observational |
Recruiting |
Study Name: TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea Condition: Myelofibrosis Polycythemia Vera Date: 2015-07-01 Interventions: Drug: TGR-1202 |
Recruiting |
Study Name: Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome Condition: Monoclonal Gammopathy of Undetermined Significance (MGUS) Chronic Lymphocytic Leukemia (CLL) Date: 2014-10-09 |
Completed |
Study Name: S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer Condition: Leukemia Myelodysplastic Syndromes Myelodysplastic/Myelopr Date: 2009-06-11 Interventions: Other: biologic sample preservation procedure |
Terminated |
Study Name: Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer Condition: Leukemia Lymphoma Myelodysplastic Syndromes Date: 2009-01-07 Interventions: Biological: alemtuzumab 43 mg |
Terminated |
Study Name: Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases Condition: Chronic Myeloproliferative Disorders Graft Versus Host Disease Date: 2008-12-20 Interventions: Biological: immunosuppressive therapy Othe |
Completed |
Study Name: Efficacy Study of Revlimid® and Low Dose Continuously Administered Melphalan to Treat Higher Risk Myelodysplastic Syndromes Condition: Myelodysplastic Syndromes Leukemia, Myelomonocytic, Chronic Date: 2008-08-29 Interventions: Drug: Lenalidomide and melphalan Lenalidomide 10 mg po daily for 21d/28 Melphalan 2 mg po daily for 21d/ |
Completed |
Study Name: Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myelogenous Leukemia, or Myeloproliferative Disorders Condition: Chronic Myeloproliferative Disorders Leukemia Myelodysplas Date: 2006-02-16 Interventions: Drug: clofarabine Drug: cyclophosphamide |
Recruiting |
Study Name: Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant Condition: Chronic Myeloproliferative Disorders Leukemia Lymphoma Date: 2006-01-24 Interventions: Procedure: psychosocial assessment and care psychosocial assessment and care |